PD-L1 Over-Expression Varies in Different Subtypes of Lung Cancer: Will This Affect Future Therapies?

Programmed death-ligand (PD-L) 1 and 2 are ligands of programmed cell death 1 (PD-1) receptor. They are members of the B7/CD28 ligand-receptor family and the most investigated inhibitory immune checkpoints at present. PD-L1 is the main effector in PD-1-reliant immunosuppression, as the PD-1/PD-L pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Asad, Pulliam, Steven, Karki, Nabin Raj, Khan, Jaffar, Jogezai, Sana, Sultan, Sandresh, Muhammad, Lal, Khan, Marjan, Jamil, Nimra, Waheed, Abdul, Belakhlef, Sami, Ghleilib, Intisar, Vail, Eric, Heneidi, Saleh, Karim, Nagla Abdel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498561/
https://www.ncbi.nlm.nih.gov/pubmed/36136862
http://dx.doi.org/10.3390/clinpract12050068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498561/
https://www.ncbi.nlm.nih.gov/pubmed/36136862
http://dx.doi.org/10.3390/clinpract12050068

Ejemplares similares